Universiteto vaistinė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,404,102 | 2,589,817 | 2,273,786 | 2,500,373 | 3,205,382 | 4,426,924 | 5,450,679 | 6,301,312 |
| Profit before tax | 90,262 | 98,667 | 56,334 | 91,554 | 135,633 | 98,867 | 104,955 | 190,716 |
| Net profit | 75,892 | 81,584 | 45,436 | 76,148 | 110,543 | 79,679 | 75,099 | 155,935 |
| Equity | 1,153,727 | 1,178,319 | 1,152,205 | 1,213,793 | 1,299,336 | 1,329,015 | 1,354,114 | 1,460,049 |
| Liabilities | 195,332 | 312,622 | 181,307 | 239,189 | 354,722 | 159,639 | 389,868 | 481,457 |
| Non-current assets | 715,868 | 717,740 | 728,339 | 725,983 | 727,408 | 722,154 | 718,913 | 731,067 |
| Current assets | 627,912 | 772,797 | 604,204 | 726,589 | 926,240 | 766,300 | 1,024,869 | 1,210,239 |
| Total assets | 1,343,780 | 1,490,537 | 1,332,543 | 1,452,572 | 1,653,648 | 1,488,454 | 1,743,782 | 1,941,306 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 244,795 | 258,460 | 299,866 |
| Social insurance contributions | - | - | - | - | - | 118,117 | 121,351 | 142,995 |
|
Financial indicators
|
||||||||
| Revenue change y/y | +10.7% | +7.7% | -12.2% | +10.0% | +28.2% | +38.1% | +23.1% | +15.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 5.6% | 5.5% | 3.4% | 5.2% | 6.7% | 5.4% | 4.3% | 8.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 6.6% | 6.9% | 3.9% | 6.3% | 8.5% | 6.0% | 5.5% | 10.7% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 3.2% | 3.2% | 2.0% | 3.0% | 3.4% | 1.8% | 1.4% | 2.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 3.8% | 3.8% | 2.5% | 3.7% | 4.2% | 2.2% | 1.9% | 3.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.2 | 0.3 | 0.2 | 0.2 | 0.3 | 0.1 | 0.3 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 77,137 | 88,289 | 95,738 | 113,225 | 146,253 | 212,493 | 274,825 | 323,144 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Universiteto vaistinė - Social security debts
The company had no debts to Sodra
Universiteto vaistinė - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Universiteto vaistine, UAB (code 121466988) is a private limited liability company operating in the retail sale of pharmaceutical products. In 2025, the latest financial year, revenue reached €6.30M, up 15.6% year on year and 42.3% over two years. Net profit increased to €155.9K, compared with €75.1K in 2024 and €79.7K in 2023, while the profit margin improved to 2.5% from 1.4% a year earlier. The company expanded its balance sheet during the period: total assets rose to €1.94M in 2025 from €1.74M in 2024 and €1.49M in 2023. Equity amounted to €1.46M, and liabilities increased to €481.5K. Long-term assets were €731.1K and short-term assets €1.21M. Key indicators point to a solid capital structure, with an equity ratio of 75.2% and debt-to-equity of 0.33. Return on equity was 10.7%, return on assets 8.0%, and asset turnover 3.25x. Revenue per employee was €331.6K, with profit per employee of €8.2K.